FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Norethindrone Acetate/Ethinyl Estradiol (Femhrt) Tablets
Status: Discontinuation
»Therapeutic Categories: Reproductive

Allergan (New 03/24/2021)

Company Contact Information:

Presentation Posting Date Related Information
Femhrt (NDC 0430-0145-14) 03/24/2021 The company has made a business decision to discontinue the product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English